PFKFB3-IN-2

CAS No. 794552-84-4

PFKFB3-IN-2( —— )

Catalog No. M36041 CAS No. 794552-84-4

PFKFB3-IN-2 is an inhibitor of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 (PFKFB3).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 45 In Stock
5MG 43 In Stock
10MG 62 In Stock
25MG 106 In Stock
50MG 155 In Stock
100MG 219 In Stock
200MG 324 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    PFKFB3-IN-2
  • Note
    Research use only, not for human use.
  • Brief Description
    PFKFB3-IN-2 is an inhibitor of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 (PFKFB3).
  • Description
    PFKFB3-IN-2 is a 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 (PFKFB3) inhibitor. PFKFB3-IN-2 has potential applications in cancer, neurodegenerative diseases, autoimmune diseases, inflammatory diseases, multiple sclerosis, metabolic diseases, angiogenesis inhibition and other diseases.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Cytoskeleton/Cell Adhesion Molecules
  • Target
    Glucokinase
  • Recptor
    Glucokinase | Phosphatase
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    794552-84-4
  • Formula Weight
    337.3
  • Molecular Formula
    C14H11NO7S
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 125 mg/mL (370.59 mM; Ultrasonic )
  • SMILES
    S(NC1=CC(O)=C(C(O)=O)C=C1)(=O)(=O)C2=CC(C(O)=O)=CC=C2
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Fedichev P, et al. Pfkfb3 inhibitors and their uses. World Intellectual Property Organization. WO2020080979.
molnova catalog
related products
  • ARRY-403

    ARRY-403 is a novel glucokinase activator that reduces fasting and postprandial blood glucose in patients with type 2 diabetes.

  • Manghaslin

    Manghaslin has considerable α-glucosidase inhibitory activity, illustrating the anti-diabetic potential of phenolic-rich litchi pulp extracts. Manghaslin also shows inhibitory activity against AChE

  • AZD-1656

    AZD-1656 is a glucokinase activator (GKA) that can cause dose-limiting hypoglycemia in normal animals used in embryofetal development studies and type 2 diabetes.